The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Shreyaskumar Patel, MD; Lor Randall, MD, FACS; Jonathan Trent, MD, PhD; and Andrew Wagner, MD, PhD, emphasize the importance of surgery and radiation in the treatment of soft tissue sarcomas, and discuss the factors affecting neoadjuvant therapy decisions.
Comments